Get the Daily Brief
Latest Biotech News
Single-Cell Study Reveals Mechanisms of Nasopharyngeal Cancer Radioresistance and Immune Escape
A Chinese research team applied integrated single-cell and spatial transcriptomic techniques to characterize molecular features of recurrent nasopharyngeal carcinoma (rNPC), uncovering key...
Sanofi Bolsters Respiratory Vaccine Pipeline With $1.15 Billion Vicebio Buy
Sanofi announced a $1.15 billion acquisition of London-based biotechnology company Vicebio, including potential milestone payments up to $450 million, to expand its respiratory virus vaccine...
Sarepta Faces FDA Scrutiny, Halts Duchenne Therapy Shipments Amid Safety Concerns
Sarepta Therapeutics has temporarily paused shipments of Elevidys, its gene therapy for Duchenne muscular dystrophy (DMD), following an escalating standoff with the FDA. The FDA requested a halt...
FDA Rejects Replimune’s Melanoma Oncolytic Virus Therapy Amid Regulatory Shift
The FDA issued a complete response letter rejecting Replimune Group’s oncolytic virus drug for advanced melanoma, citing inadequate single-arm trial design and patient heterogeneity. The agency...
Neuralink Hits Milestone with Two Brain-Computer Interface Implants in a Day
Neuralink, Elon Musk’s neurotechnology company, successfully performed two brain-computer interface (BCI) implants within 24 hours, marking a significant operational milestone. With nine human...
Prime Editing Advances for Rare Neurodevelopmental Disorder in Animal Models
Researchers at the Broad Institute and Jackson Laboratory demonstrated that prime editing can successfully correct five genetic mutations causing alternating hemiplegia of childhood (AHC), a...
Largest Four-Day Workweek Trial Shows Improved Employee Wellbeing Without Productivity Loss
A multinational study spanning six countries found that transitioning to a four-day workweek, without pay reduction, enhances employee happiness, mental and physical health, and job satisfaction...
Genetic Signatures Partners with Tecan and Repado to Automate Infectious Disease Testing
Australian molecular diagnostics firm Genetic Signatures announced a strategic partnership with automation provider Tecan and IVD software developer Repado to create fully integrated syndromic...
Danaher Reports 4% Revenue Growth With Continued China Market Headwinds
Danaher reported second quarter revenues of $5.94 billion, up 4% year-over-year, driven primarily by robust growth in its bioprocessing division despite challenges in China’s diagnostics business....
FDA Panel Questions Safety and Efficacy of Antidepressants in Pregnancy, Calls for Stricter Labeling
A Food and Drug Administration advisory panel expressed concerns over the use of selective serotonin reuptake inhibitors (SSRIs) during pregnancy, discussing potential risks to fetal...
Sarepta and FDA Face Off Over Duchenne Gene Therapy
Sarepta Therapeutics is embroiled in a regulatory crisis as the FDA has requested a voluntary halt to shipments of Elevidys, Sarepta's gene therapy for Duchenne muscular dystrophy (DMD), following...
Sanofi Expands Respiratory Vaccine Portfolio with Vicebio Acquisition
Sanofi announced a $1.15 billion upfront acquisition of UK-based biotech Vicebio, gaining early-stage combination vaccine candidates targeting respiratory syncytial virus (RSV) and human...
Prime Editing Shows Promise Against Rare Neurodevelopmental Disorders
Researchers from the Broad Institute and Jackson Laboratory utilized prime editing—a precision CRISPR-derived gene editing technology—to correct multiple ATP1A3 gene mutations responsible for...
Alkermes Advances Narcolepsy Treatment With Phase 2 Success
Alkermes reported positive Phase 2 results for alixorexton, an orexin receptor agonist targeting narcolepsy type 1. The oral drug demonstrated statistically significant improvements in wakefulness...
Danaher Posts Solid Q2 Growth Fueled by Bioprocessing Surge
Danaher reported Q2 revenues of $5.94 billion, reflecting a 4% increase year over year and surpassing analyst estimates. Growth was driven primarily by an 8% revenue rise in its biotechnology...
Jura Bio Debuts AI-Driven Antibody Design Platform
Jura Bio introduced VISTA, an AI-controlled data loop system designed to accelerate de novo antibody design for cancer therapeutics. The platform integrates generative modeling, high-throughput...
UCSF Study Identifies Anticancer Drug Combo for Alzheimer’s Disease
Scientists at UCSF and Gladstone Institutes used computational approaches to identify a combination of two FDA-approved anticancer drugs, letrozole and irinotecan, which reversed Alzheimer’s...
University of Oklahoma Secures $2.8M to Study Friedrich’s Ataxia Genetics
The University of Oklahoma team led by Sanjay Bidichandani received a $2.8 million Department of Defense grant to investigate genotype diversity in Friedrich’s ataxia. Using long-read sequencing,...
OxNanopore Reports 25% Revenue Surge on Sequencing Demand
Oxford Nanopore Technologies reported preliminary H1 2025 revenues of approximately £105 million, representing a 25% year-over-year increase driven by strong growth in research and applied markets...
Omega Funds Closes $647M Biotech Venture Capital Fund
Boston and Geneva-based biotech investor Omega Funds secured $647 million for its eighth venture capital fund, matching the size of its 2021 raise. The fund targets innovative life sciences...